Fermented Seasoning Peptide Bitterness Control

Solution Overview

Problem

Existing fermented seasonings rich in peptides often exhibit bitterness, making them difficult to ingest orally, and current methods to mask bitterness are insufficient in terms of effectiveness and production cost.

Innovation Solution

A fermented seasoning is developed using Aspergillus culture with controlled leucine aminopeptidase activity, combined with fermentation conditions and the addition of a yeast strain, which results in a high peptide content without bitterness, offering a mellow and rich deliciousness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If peptides are produced by hydrolyzing protein-containing material with protease preparation, then peptide content is increased, but bitterness increases and oral ingestion becomes difficult

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent introduces leucine aminopeptidase as an intermediary enzyme that selectively hydrolyzes leucine-containing peptides. This mediator enzyme allows controlled degradation of specific peptide types while preserving others, thereby reducing bitterness without significantly lowering overall peptide content. The leucine aminopeptidase acts as a selective filter that processes peptides in a controlled manner.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the enzymatic parameter by introducing leucine aminopeptidase activity alongside protease activity. This parameter change enables selective hydrolysis of leucine-containing peptides at controlled rates. By adjusting the leucine aminopeptidase activity level, the patent optimizes the balance between peptide degradation (reducing bitterness) and peptide preservation (maintaining content).

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If peptidase activity is increased to degrade peptides into amino acids, then deliciousness is improved, but peptide content is reduced

Engineering Contradiction:
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The patent segments the peptide degradation process into two distinct enzymatic stages: first, proteases hydrolyze proteins into peptides; second, leucine aminopeptidase selectively degrades leucine-containing peptides into amino acids. This segmentation allows controlled progression through different degradation stages, preserving peptides that are not leucine-containing while converting only specific peptide types into amino acids, thus maintaining both peptide content and deliciousness.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by making the peptidase activity selective for leucine-containing peptides rather than degrading all peptides uniformly. This localized enzymatic action targets only specific peptide substrates (those containing leucine at the N-terminus), leaving other peptide types intact. Consequently, the deliciousness improvement comes from converting problematic leucine-containing peptides, while overall peptide content is preserved.

Inventive Principle:
Principle #3Local quality

3Object-affected harmful factors

If masking agents are added to reduce bitterness, then oral ingestion is improved, but production cost increases and new foul taste may be generated

Engineering Contradiction:
Core Design Contradiction:
Object-affected harmful factorsVSEase of manufacture

Solution Approach 1:

The patent employs self-service by using leucine aminopeptidase to automatically and selectively convert bitter-tasting leucine-containing peptides into amino acids during the fermentation process itself. This self-regulating enzymatic system eliminates the need for external masking agents. The enzyme system serves its own function of reducing bitterness through controlled hydrolysis, transforming the harmful component into a beneficial one (amino acids contribute to umami flavor) without requiring additional costly additives.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The seasoning effectively masks the bitterness of peptides, allowing for easy oral ingestion while maintaining high peptide content, providing desirable taste and potential physiological benefits.

Implementation Method 1

The deliciousness is produced by the solubilization of material proteins to be peptides through the activity of proteases

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

a method for hydrolyzing a protein-containing material with a protease preparation

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

additional degradation of the peptides into amino acids including glutamic acid by the activity of peptidases

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 4

the activity of peptidases

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 5

fermentation conditions and the addition of a yeast strain

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentEP2298085B1Peptide-containing seasoning
Publication Date: 2015.09.09
  • EP2298085B1 patent drawingFigure 1
  • EP2298085B1 patent drawingFigure 2
  • EP2298085B1 patent drawingFigure 3

AI summary

A fermented seasoning which does not have the bitterness specific to peptides and can be easily ingested orally, in spite of containing large amount of peptides is provided. Namely, a fermented seasoning obtained by adding salt water to an Aspergillus culture or a mixture of the Aspergillus culture with a plant-derived protein material and by controlling the leucine aminopeptidase-I activity in the moromi to be 1.0 U/ml or less, and also controlling the leucine aminopeptidase-II activity to be 0.5 U/ml or less, within 10 days after the preparation.